Seurat assets sold to Soane Biosciences:
This article was originally published in Clinica
Executive Summary
US microchip systems developer Soane Biosciences has purchased virtually all the assets of Seurat Analytical Systems. It will use the private company's patented high-thoroughput processing and sample analysis technologies in its own microchip-based analytical systems.